Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

1.

Preface.

Lawton G, Witty D.

Prog Med Chem. 2015;54:ix-xi. doi: 10.1016/S0079-6468(15)00009-0. No abstract available.

PMID:
25727707
2.

Preface.

Lawton G, Witty D.

Prog Med Chem. 2014;53:v-vi. doi: 10.1016/B978-0-444-63380-4.09989-3. No abstract available.

PMID:
24418611
3.

Glucokinase. Preface.

Lawton G, Witty DR.

Prog Med Chem. 2013;52:v-vii. doi: 10.1016/B978-0-444-62652-3.10000-6. No abstract available.

PMID:
23384669
4.

Basal cell carcinoma arising in association with trichoepithelioma in a case of Brooke-Spiegler syndrome with a novel genetic mutation in CYLD.

Melly L, Lawton G, Rajan N.

J Cutan Pathol. 2012 Oct;39(10):977-8. doi: 10.1111/j.1600-0560.2012.01952.x. Epub 2012 Aug 9. No abstract available.

PMID:
22882113
5.

The large scale restructuring of pharmaceutical company research function. Preface.

Lawton G, Witty DR.

Prog Med Chem. 2012;51:v-vi. doi: 10.1016/B978-0-12-396493-9.00005-4. No abstract available.

PMID:
22520474
6.

Drug discovery projects. Preface.

Lawton G, Witty DR.

Prog Med Chem. 2011;50:v-vi. No abstract available.

PMID:
21476319
7.

A pedicled latissimus dorsi myocutaneous flap for early reconstruction of cervicocranial necrotising fasciitis.

Alexander K, Lawton G, Macquillan A.

Indian J Plast Surg. 2010 Jul;43(2):224-5. doi: 10.4103/0970-0358.73470. No abstract available.

8.

Shaping the military wound: issues surrounding the reconstruction of injured servicemen at the Royal Centre for Defence Medicine.

Evriviades D, Jeffery S, Cubison T, Lawton G, Gill M, Mortiboy D.

Philos Trans R Soc Lond B Biol Sci. 2011 Jan 27;366(1562):219-30. doi: 10.1098/rstb.2010.0237.

9.

Medicinial chemistry. Preface.

Lawton G, Witty DR.

Prog Med Chem. 2010;49:v-vi. doi: 10.1016/S0079-6468(10)49007-4. No abstract available.

PMID:
20855036
10.

Medicines discovery in the 21st century: the case for a stakeholder corporation.

Dixon J, England P, Lawton G, Machin P, Palmer A.

Drug Discov Today. 2010 Sep;15(17-18):700-3. doi: 10.1016/j.drudis.2010.07.004. Epub 2010 Aug 1.

PMID:
20678583
11.

Novel haemostatic dressings.

Lawton G, Granville-Chapman J, Parker PJ.

J R Army Med Corps. 2009 Dec;155(4):309-14. Review. No abstract available.

PMID:
20397608
12.

Beginning of the 'numbers' era of medicinal chemistry. Preface.

Lawton G, Witty DR.

Prog Med Chem. 2009;48:v-vi. doi: 10.1016/S0079-6468(09)04810-3. No abstract available.

PMID:
19942039
13.

Effect of potential amine prodrugs of selective neuronal nitric oxide synthase inhibitors on blood-brain barrier penetration.

Silverman RB, Lawton GR, Ralay Ranaivo H, Chico LK, Seo J, Watterson DM.

Bioorg Med Chem. 2009 Nov 1;17(21):7593-605. doi: 10.1016/j.bmc.2009.08.065. Epub 2009 Sep 6.

14.

Synthesis and enzymatic evaluation of 2- and 4-aminothiazole-based inhibitors of neuronal nitric oxide synthase.

Lawton GR, Ji H, Martásek P, Roman LJ, Silverman RB.

Beilstein J Org Chem. 2009 Jun 4;5:28. doi: 10.3762/bjoc.5.28.

15.

L337H mutant of rat neuronal nitric oxide synthase resembles human neuronal nitric oxide synthase toward inhibitors.

Fang J, Ji H, Lawton GR, Xue F, Roman LJ, Silverman RB.

J Med Chem. 2009 Jul 23;52(14):4533-7. doi: 10.1021/jm900380j.

16.

Vertical disintegration: a strategy for pharmaceutical businesses in 2009?

Dixon J, Lawton G, Machin P.

Nat Rev Drug Discov. 2009 Jun;8(6):435. doi: 10.1038/nrd2918. No abstract available.

PMID:
19483701
17.

Acceptability and effectiveness of a strategy for the communication of the diagnosis of psychogenic nonepileptic seizures.

Hall-Patch L, Brown R, House A, Howlett S, Kemp S, Lawton G, Mayor R, Smith P, Reuber M; NEST collaborators.

Epilepsia. 2010 Jan;51(1):70-8. doi: 10.1111/j.1528-1167.2009.02099.x. Epub 2009 Apr 27.

PMID:
19453708
18.

Progress in medicinal chemistry. Preface.

Lawton G, Witty DR.

Prog Med Chem. 2009;47:v-vi. doi: 10.1016/S0079-6468(08)00208-7. No abstract available.

PMID:
19328287
19.

Crystal structures of constitutive nitric oxide synthases in complex with de novo designed inhibitors.

Igarashi J, Li H, Jamal J, Ji H, Fang J, Lawton GR, Silverman RB, Poulos TL.

J Med Chem. 2009 Apr 9;52(7):2060-6. doi: 10.1021/jm900007a.

20.

Analogues of 2-aminopyridine-based selective inhibitors of neuronal nitric oxide synthase with increased bioavailability.

Lawton GR, Ralay Ranaivo H, Chico LK, Ji H, Xue F, Martásek P, Roman LJ, Watterson DM, Silverman RB.

Bioorg Med Chem. 2009 Mar 15;17(6):2371-80. doi: 10.1016/j.bmc.2009.02.017. Epub 2009 Feb 14.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk